{{Rsnum
|rsid=10959672
|Chromosome=9
|position=11257448
|Orientation=plus
|GMAF=0.2727
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 10.6 | 54.0 | 35.4
| HCB | 13.2 | 42.6 | 44.1
| JPT | 15.9 | 46.9 | 37.2
| YRI | 0.7 | 10.3 | 89.0
| ASW | 3.6 | 12.5 | 83.9
| CHB | 13.2 | 42.6 | 44.1
| CHD | 16.5 | 45.9 | 37.6
| GIH | 9.9 | 51.5 | 38.6
| LWK | 1.8 | 14.5 | 83.6
| MEX | 6.9 | 56.9 | 36.2
| MKK | 2.6 | 29.5 | 67.9
| TSI | 3.9 | 49.0 | 47.1
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=5E-7
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}